Table 1.

List of significantly dysregulated RMPs identified using dysregulation score-based analysis

Short name	Cancer type	Upregulated RMPs	Downregulated RMPs
ACC	Adrenocortical carcinoma	BUD23, FBL, LAGE3, TRMT112, VIRMA	ADAT2, APOBEC3G, TARBP1
BLCA	Bladder urothelial carcinoma	HENMT1	ADARB1
BRCA	Breast invasive carcinoma	LAGE3	TRMT9B
CESC	Cervical squamous cell carcinoma and endocervical adenocarcinoma	APOBEC3A, HENMT1	–
COAD	Colon adenocarcinoma	APOBEC1, DKC1, HENMT1	ADARB1
ESCA	Esophageal carcinoma	HENMT1, RBM15, ZC3H13	ADAD2, METTL17
GBM	Glioblastoma multiforme	APOBEC3G, HSD17B10	ADARB2, FBLL1, TARBP1
HNSC	Head and neck squamous cell carcinoma	HENMT1	–
KICH	Kidney chromophobe	ISCU	–
KIRC	Kidney renal clear cell carcinoma	APOBEC3G	–
KIRP	Kidney renal papillary cell carcinoma	METTL27	–
LAML	Acute myeloid leukemia	APOBEC3A, HENMT1	–
LGG	Brain lower-grade glioma	HSD17B10, TRMT5	ADARB1, HENMT1, TARBP1
LIHC	Liver hepatocellular carcinoma	LAGE3, METTL27, TARBP1	ADAT2, METTL17, NSUN6, TRMT11, ZC3H13
LUAD	Lung adenocarcinoma	LAGE3, METTL1, TFB2M	ADARB1, APOBEC3A,TRMT9B
LUSC	Lung squamous cell carcinoma	DKC1, FBL, LAGE3, METTL1, METTL8	ADARB1, TRMT9B
OV	Ovarian serous cystadenocarcinoma	–	YTHDC2
PAAD	Pancreatic adenocarcinoma	APOBEC1, APOBEC3G, HENMT1	QTRT1, WDR6
PCPG	Pheochromocytoma and paraganglioma	FBLL1	MPST
PRAD	Prostate adenocarcinoma	–	APOBEC3G, METTL17
READ	Rectum adenocarcinoma	APOBEC1, DKC1, HENMT1	ADARB1
SARC	Sarcoma	HENMT1	ADARB1, ISCU, SERGEF
SKCM	Skin cutaneous melanoma	APOBEC3G	–
STAD	Stomach adenocarcinoma	HENMT1	METTL17,TRMT2A, WDR6
TGCT	Testicular germ cell tumors	EMG1, FBL, HNRNPC, HSD17B10, LAGE3, METTL9	ADAD1, ADAD2
THCA	Thyroid carcinoma	LAGE3, TRMT112	ADAT2, METTL17, TRMT9B, TRMU
UCEC	Uterine corpus endometrial carcinoma	LAGE3	ADARB1
UCS	Uterine carcinosarcoma	FBL, HENMT1, HSD17B10, LAGE3, TRMT112